Identification of a circulating microvesicle protein network involved in ST-elevation myocardial infarction

Summary

Membrane microvesicles (MVs) are released from activated cells, most notably platelets, into the circulation. They represent an important mode of intercellular communication, and their number is increased in patients with acute coronary syndromes. We present here a differential proteomic analysis of plasma MVs from ST-elevation myocardial infarction (STEMI) patients and stable coronary artery disease (SCAD) controls. The objective was the identification of MVs biomarkers/drug targets that could be relevant for the pathogenesis of the acute event. Proteome analysis was based on 2D-DIGE, and mass spectrometry. Validations were by western blotting in an independent cohort of patients and healthy individuals. A systems biology approach was used to predict protein-protein interactions and their relation with disease. Following gel image analysis, we detected 117 protein features that varied between STEMI and SCAD groups (fold change cut-off ≥2; p<0.01). From those, 102 were successfully identified, corresponding to 25 open-reading frames (ORFs). Most of the proteins identified are involved in inflammatory response and cardiovascular disease, with 11 ORFs related to infarction. Among others, we report an up-regulation of α2-macroglobulin isoforms, fibrinogen, and viperin in MVs from STEMI patients. Interestingly, several of the proteins identified are involved in thrombogenesis (e.g. α2-macroglobulin, and fibrinogen). In conclusion, we provide a unique panel of proteins that vary between plasma MVs from STEMI and SCAD patients and that might constitute a promising source of biomarkers/drug targets for myocardial infarction.

Keywords

Microvesicles - proteomics - ST-elevation myocardial infarction

• References

• 1 Raposo G, Stoorvogel W. Extracellular vesicles: exosomes, microvesicles, and friends. J Cell Biol 2013; 200: 373-383.
• 2 Libby P, Ridker PM, Hansson GK. Leducq Transatlantic Network on Atherothrombosis. Inflammation in atherosclerosis: from pathophysiology to practice. J Am Coll Cardiol 2009; 54: 2129-2138.
• 3 Mallat Z, Benamer H, Hugel B. et al. Elevated levels of shed membrane micro-particles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes. Circulation 2000; 101: 841-843.
• 4 Biasucci LM, Porto I, Di Vito L. et al. Differences in microparticle release in patients with acute coronary syndrome and stable angina. Circ J 2012; 76: 2174-2182.
• 5 Jung C, Sörensson P, Saleh N. et al. Circulating endothelial and platelet derived microparticles reflect the size of myocardium at risk in patients with ST-elevation myocardial infarction. Atherosclerosis 2012; 221: 226-231.
• 6 Morel O, Hugel B, Jesel L. et al. Circulating procoagulant microparticles and soluble GPV in myocardial infarction treated by primary percutaneous transluminal coronary angioplasty. A possible role for GPIIb-IIIa antagonists. J Thromb Haemost 2004; 2: 1118-1126.
• 7 Bernal-Mizrachi L, Jy W, Jimenez JJ. et al. High levels of circulating endothelial microparticles in patients with acute coronary syndromes. Am Heart J 2003; 145: 962-970.
• 8 Stępień E, Stankiewicz E, Zalewski J. et al. Number of microparticles generated during acute myocardial infarction and stable angina correlates with platelet activation. Arch Med Res 2012; 43: 31-35.
• 9 Parguiña AF, Grigorian-Shamagian L, Agra RM. et al. Variations in platelet proteins associated with ST-elevation myocardial infarction: novel clues on pathways underlying platelet activation in acute coronary syndromes. Arterioscler Thromb Vasc Biol 2011; 31: 2957-2964.
• 10 Parguiña AF, Grigorian-Shamajian L, Agra RM. et al. Proteins involved in platelet signaling are differentially regulated in acute coronary syndrome: a proteomic study. PLoS One 2010; 5: e13404.
• 11 Lacroix R, Judicone C, Mooberry M. et al. Standardization of pre-analytical variables in plasma microparticle determination: results of the International Society on Thrombosis and Haemostasis SSC Collaborative workshop. J Thromb Haemost 2013; 11: 1190-1193.
• 12 Lacroix R, Judicone C, Poncelet P. et al. Impact of pre-analytical parameters on the measurement of circulating microparticles: towards standardization of protocol. J Thromb Haemost 2012; 10: 437-446.
• 13 García A. Two-dimensional gel electrophoresis in platelet proteomics research. Methods Mol Med 2007; 139: 339-353.
• 14 Ramacciotti E, Hawley AE, Wrobleski SK. et al. Proteomics of microparticles after deep venous thrombosis. Thromb Res 2010; 125: e269-274.
• 15 Shevchenko A, Jensen ON, Podtelejnikov AV. et al. Linking genome and proteome by mass spectrometry: large-scale identification of yeast proteins from two dimensional gels. Proc Natl Acad Sci USA 1996; 93: 14440-14445.
• 16 Mosesson MW. Fibrinogen gamma chain functions. J Thromb Haemost 2003; 1: 231-238.
• 17 Olofsson PS, Jatta K, Wågsäter D. et al. The antiviral cytomegalovirus inducible gene 5/viperin is expressed in atherosclerosis and regulated by proinflammatory agents. Arterioscler Thromb Vasc Biol 2005; 25: e113-116.
• 18 Kashyap RS, Nayak AR, Deshpande PS. et al. Inter-alpha-trypsin inhibitor heavy chain 4 is a novel marker of acute ischemic stroke. Clin Chim Acta 2009; 402: 160-163.
• 19 Bísaro de Lorenc L, Ramos AM, Sánchez MC. et al. Structural evaluation of plasma alpha2-macroglobulin in acute pancreatitis. Clin Chem Lab Med 2005; 43: 1183-1189.
• 20 Chin KC, Cresswell P. Viperin (cig5), an IFN-inducible antiviral protein directly induced by human cytomegalovirus. Proc Natl Acad Sci USA 2001; 98: 15125-15130.
• 21 Piccin A, Murphy WG, Smith OP. Circulating microparticles: pathophysiology and clinical implications. Blood Rev 2007; 21: 157-171.
• 22 Suades R, Padró T, Alonso R. et al. Lipid-lowering therapy with statins reduces microparticle shedding from endothelium, platelets and inflammatory cells. Thromb Haemost 2013; 110: 366-377.
• 23 Suades R, Padró T, Vilahur G. et al. Circulating and platelet-derived microparticles in human blood enhance thrombosis on atherosclerotic plaques. Thromb Haemost 2012; 108: 1208-1219.
• 24 Shai E, Rosa I, Parguiña AF. et al. Comparative analysis of platelet-derived microparticles reveals differences in their amount and proteome depending on the platelet stimulus. J Proteomics 2012; 76 Spec No. 287-296.
• 25 Abdullah NM, Kachman M, Walker A. et al. Microparticle surface protein are associated with experimental venous thrombosis: a preliminary study. Clin Appl Thromb Hemost 2009; 15: 201-208.